Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005787 | signal peptidase complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1905368 | peptidase complex | 3 | 1 |
Related structures:
AlphaFold database: A4H358
Term | Name | Level | Count |
---|---|---|---|
GO:0006465 | signal peptide processing | 5 | 1 |
GO:0006508 | proteolysis | 4 | 1 |
GO:0006518 | peptide metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0016485 | protein processing | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0051604 | protein maturation | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0008233 | peptidase activity | 3 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 196 | 200 | PF00656 | 0.438 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.404 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.399 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 60 | 64 | PF00082 | 0.330 |
DOC_MAPK_FxFP_2 | 188 | 191 | PF00069 | 0.517 |
DOC_MAPK_gen_1 | 130 | 139 | PF00069 | 0.530 |
DOC_MAPK_MEF2A_6 | 133 | 141 | PF00069 | 0.512 |
DOC_PP4_FxxP_1 | 164 | 167 | PF00568 | 0.621 |
DOC_PP4_FxxP_1 | 188 | 191 | PF00568 | 0.501 |
DOC_USP7_MATH_1 | 204 | 208 | PF00917 | 0.559 |
DOC_WW_Pin1_4 | 162 | 167 | PF00397 | 0.589 |
LIG_14-3-3_CanoR_1 | 140 | 148 | PF00244 | 0.563 |
LIG_14-3-3_CanoR_1 | 31 | 40 | PF00244 | 0.549 |
LIG_BRCT_BRCA1_1 | 160 | 164 | PF00533 | 0.594 |
LIG_BRCT_BRCA1_1 | 184 | 188 | PF00533 | 0.606 |
LIG_BRCT_BRCA1_1 | 85 | 89 | PF00533 | 0.349 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.548 |
LIG_FHA_1 | 32 | 38 | PF00498 | 0.527 |
LIG_LIR_Apic_2 | 161 | 167 | PF02991 | 0.627 |
LIG_LIR_Apic_2 | 185 | 191 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 168 | 177 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 84 | 95 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 144 | 150 | PF02991 | 0.663 |
LIG_LIR_Nem_3 | 168 | 173 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.531 |
LIG_LIR_Nem_3 | 28 | 33 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 39 | 43 | PF02991 | 0.588 |
LIG_LIR_Nem_3 | 84 | 90 | PF02991 | 0.334 |
LIG_NRP_CendR_1 | 208 | 211 | PF00754 | 0.326 |
LIG_PCNA_yPIPBox_3 | 195 | 209 | PF02747 | 0.599 |
LIG_PTB_Apo_2 | 5 | 12 | PF02174 | 0.517 |
LIG_PTB_Phospho_1 | 5 | 11 | PF10480 | 0.514 |
LIG_SH2_CRK | 30 | 34 | PF00017 | 0.564 |
LIG_SH2_NCK_1 | 11 | 15 | PF00017 | 0.553 |
LIG_SH2_NCK_1 | 170 | 174 | PF00017 | 0.551 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.300 |
LIG_SH3_3 | 143 | 149 | PF00018 | 0.542 |
LIG_TRAF2_1 | 193 | 196 | PF00917 | 0.437 |
LIG_TYR_ITIM | 41 | 46 | PF00017 | 0.651 |
LIG_TYR_ITSM | 166 | 173 | PF00017 | 0.460 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.629 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.186 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.578 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.332 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.565 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.622 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.709 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.468 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.601 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.503 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.266 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.320 |
MOD_PIKK_1 | 139 | 145 | PF00454 | 0.588 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.545 |
MOD_Plk_1 | 173 | 179 | PF00069 | 0.587 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.523 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.644 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.451 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.340 |
MOD_Plk_4 | 98 | 104 | PF00069 | 0.412 |
MOD_ProDKin_1 | 162 | 168 | PF00069 | 0.586 |
MOD_SUMO_for_1 | 151 | 154 | PF00179 | 0.515 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.531 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.497 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.558 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.574 |
TRG_ER_diLys_1 | 208 | 211 | PF00400 | 0.633 |
TRG_NLS_MonoExtN_4 | 127 | 134 | PF00514 | 0.560 |
TRG_Pf-PMV_PEXEL_1 | 130 | 135 | PF00026 | 0.377 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JMH0 | Bodo saltans | 30% | 77% |
A0A1X0P325 | Trypanosomatidae | 33% | 94% |
A0A3S5H4U6 | Leishmania donovani | 75% | 100% |
A0A3S5ISA1 | Trypanosoma rangeli | 26% | 92% |
A4HRF5 | Leishmania infantum | 75% | 100% |
C9ZXH9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 96% |
E9AC23 | Leishmania major | 74% | 100% |
E9AJC0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |